drugset / Trial / NCT02242903
A Study of LY3079514 in Healthy Participants
RandomizedSingle-groupDouble-blindBasic science
Summary
The main purpose of this study is to evaluate the safety and how well the body will handle a single dose of study drug, LY3079514. This study will last about 12 weeks for each participant.
Timeline
- Start
- 2014-10
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY3079514 | Unknown | — | Subcutaneous |
Indications
No indication recorded.